[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100375764":3},{"organization":4,"armGroups":7,"interventions":47,"overallOfficials":53,"centralContacts":53,"locations":59,"responsibleParty":83,"collaborators":53,"id":87,"slug":53,"hasResults":88,"nctId":89,"briefTitle":90,"officialTitle":91,"acronym":53,"eligibilityCriteria":92,"healthyVolunteers":88,"sex":93,"minAge":94,"maxAge":53,"enrollmentInfo":95,"targetDuration":53,"studyType":98,"phases":99,"briefSummary":101,"conditions":102,"keywords":109,"overallStatus":62,"whyStopped":53,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":121},{"fullName":5,"class":6},"University Hospital Tuebingen","OTHER",[8,14,18,22,26,30,34,38,42],{"label":9,"type":10,"description":11,"interventionNames":12},"Rectal and anal cancer","EXPERIMENTAL","In this arm patients with rectal and anal cancer are recruited.",[13],"Radiation: Radiotherapy on the MR-Linac",{"label":15,"type":10,"description":16,"interventionNames":17},"Prostate cancer","In this arm patients with prostate cancer are recruited.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Head and neck cancer","In this arm patients with head and neck cancers are recruited.",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Esophageal cancer","In this arm patients with esophageal cancer are recruited.",[13],{"label":27,"type":10,"description":28,"interventionNames":29},"Breast Cancer","In this arm patients with breast cancer are recruited.",[13],{"label":31,"type":10,"description":32,"interventionNames":33},"Central nervous system tutors","In this arm patients with tumors of the central nervous system are recruited.",[13],{"label":35,"type":10,"description":36,"interventionNames":37},"Palliative treatments","In this arm patients with palliative treatments are recruited.",[13],{"label":39,"type":10,"description":40,"interventionNames":41},"Other","In this arm patients with other tumors are recruited.",[13],{"label":43,"type":10,"description":44,"interventionNames":45},"Imaging only","In this arm patients receive only imaging on the MR-Linac",[46],"Diagnostic Test: Imaging on the MR Linac",[48,54],{"type":49,"name":50,"description":51,"armGroupLabels":52,"otherNames":53},"RADIATION","Radiotherapy on the MR-Linac","Radiotherapy is performed on the 1.5 T MR Linac",[27,31,23,19,39,35,15,9],null,{"type":55,"name":56,"description":57,"armGroupLabels":58,"otherNames":53},"DIAGNOSTIC_TEST","Imaging on the MR Linac","Only imaging performed on the MR Linac",[43],[60],{"facility":61,"status":62,"city":63,"state":64,"zip":65,"country":66,"cosmosGeoPoint":67,"geoPoint":72,"contacts":73},"University Hospital Tübingen, Department of Radiation Oncology","RECRUITING","Tübingen","Baden-Wurttemberg","72076","Germany",{"type":68,"coordinates":69},"Point",[70,71],9.05222,48.52266,{"lat":71,"lon":70},[74,79],{"name":75,"role":76,"phone":77,"phoneExt":53,"email":78},"Daniel Zips, MD, Prof","CONTACT","+49 (0) 7071 29-85990","ro-info@med.uni-tuebingen.de",{"name":80,"role":76,"phone":81,"phoneExt":53,"email":82},"Cihan Gani, MD","+49 (0)7071 29-82165","cihan.gani@med.uni-tuebingen.de",{"type":84,"investigatorFullName":85,"investigatorTitle":86,"investigatorAffiliation":5,"oldNameTitle":53,"oldOrganization":53},"PRINCIPAL_INVESTIGATOR","Dr. Cihan Gani","Lead of gastrointestinal radiation oncology","100375764",false,"NCT04172753","Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac","Feasibility of Imaging and Radiotherapy on a Novel 1.5 T Hybrid Magnetic Resonance Imaging - Linear Accelerator System (MR-Linac)","Inclusion Criteria:\n\n* existing indication for radiation therapy\n* minimum age 18 years, no upper age limit\n* capacity for consent\n* Informed consent\n\nExclusion Criteria:\n\n* contraindication for MRI (claustrophobia, metallic implants not applicable for MRI\n* pregnancy","ALL","18 Years",{"count":96,"type":97},472,"ESTIMATED","INTERVENTIONAL",[100],"NA","This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.",[103,104,105,27,106,107,108],"Rectal Cancer","Head and Neck Cancer","Liver Cancer","Prostate Cancer","Oligometastasis","Esophageal Cancer",[110,111],"Radiotherapy","Adaptive Radiotherapy","2019-11-19",{"date":114,"type":115},"2019-11-21","ACTUAL",{"date":117,"type":115},"2018-05-09",{"date":119,"type":97},"2027-05-09",{"name":5,"class":6},1]